Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today
Shares of Inovio Pharmaceuticals (NASDAQ: INO) and Vir Biotechnology (NASDAQ: VIR), two companies developing drugs for the coronavirus outbreak in China, are down today on word that Gilead Sciences (NASDAQ: GILD) looks to have beaten the companies to the punch, setting up a research collaboration with Chinese authorities to run a clinical trial for its antiviral medication remdesivir.
As of 1:46 p.m. EST on Monday, Inovio had fallen 14.5%, while Vir was down 16.2%.
Image source: Getty Images.
Source Fool.com
